Bringing the fundamentals into focus…
Back to Aura Biosciences, Inc.
How Aura Biosciences, Inc. stacks up
AURA · against 484 other Healthcare companies of similar size
Valuation
8/ 100
Near the bottom of its peers.
Ranked #317 of 485 · scores higher than 12% of peers
Bars: peers in each 10-point band of the valuation score169 peers with a valuation score of 0–9, including AURA · Click a bar to see the companies
Why valuation scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its EBITDA yield, earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -40.3% vs peer median 4.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -20.2% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -16.0% vs peer median 0.0%
Metric by metric
Position: dot = AURA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AURA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 473 reported | -27.7% | 0.7% | 8% | 30% | |
| EBITDA yieldHigher is better · 489 reported | -40.3% | 3.6% | 5% | 50% | |
| Free cash flow yieldHigher is better · 204 reported | -16.0% | -4.2% | 24% | 20% | |
| Book yieldHigher is better · 483 reported | 48.8% | 45.6% | 53% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around AURA| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 6.50T IDR (≈$403M) | 99 | 69 | |
| 317 | 794M USD | 8 | ||
| 317 | 891M USD | 8 | ||
| 317 | 487M USD | 8 | 24 | |
| 317 | 782M USD | 8 | 35 | |
| 317 | 647M USD | 8 | 40 | |
| 317 | 377M USD | 8 | 29 | |
| 317 | 334M USD | 8 | 36 | |
| 317 | 546M USD | 8 | 31 | |
| 317 | 815M USD | 8 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score